Search
11 stories for“diabetes prevalence”
IDF figures put UAE adult prevalence at 20.7 per cent and Saudi Arabia at 23.1 per cent, against a global figure around a tenth. The explanation is not one thing, and one of the contributing factors is barely three generations old.
Jul 16, 2026
Ozempic, Wegovy and Mounjaro are all prescribable in the UAE, but shortages and insurance gaps shape who can actually get them.
Mar 10, 2025
Pregnancy is an accidental stress test of the pancreas, and gestational diabetes is a failed one. The glucose normalises after birth, the elevated lifetime risk does not, and the follow-up appointment that would catch it is missed constantly.
Jul 31, 2026
The label is contested, the thresholds differ between guidelines, and most people who have it never progress. It is also the one point in this whole condition where a trial showed you can change the outcome by more than half.
Jul 10, 2026
Semaglutide hits one receptor and tirzepatide hits two. The third one retatrutide adds is glucagon, which does the opposite of what a diabetes drug is supposed to do. It is also where the liver results and the safety questions both come from.
Aug 20, 2026
A health ministry does not issue a public warning about an eating plan for the sake of it. This one followed reports of people reaching intensive care after stopping insulin.
Jun 13, 2026
Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024
Large trials with more than 30,000 participants found vitamin D pills do little for people who are not deficient, reshaping decades of assumptions.
Jan 20, 2026
